Anna Loengard, M.D.
Board Member
Clover Health Investments, Corp. /De (CLOV)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anna Loengard, M.D.
Anna Loengard, M.D. is recorded as Board Member at Clover Health Investments, Corp. /De (CLOV). Clover Health Investments, Corp. /De reported in an 8-K filed November 30, 2022 that Anna Loengard, M.D. was appointed Class I director, effective November 28, 2022.
“On November 28, 2022, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Anna Loengard, M.D., to serve as a Class I director of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Clover Health Investments, Corp. /De
Other people whose current roles at this company are on record from its filings.
- Andrew Toy CEO, Board Member
- Conrad Wai CEO, CTO
- Jamie L. Reynoso CEO, COO
- Vivek Garipalli Chairman, Board Member
- Clay Thornton CFO
- Joseph Wagner CFO
- Gia Lee General Counsel
- Karen Soares General Counsel
- Joseph (Joe) Oldakowski Chief Accounting Officer
- Mark Herbers Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.